Regulatory Trends about Titanium Dioxide (Mainly in Europe)

Key Points

• The aim is to trace the regulatory developments concerning the carcinogenic classification of titanium dioxide and industry responses.
• Review of the carcinogenic classification process and court rulings in Europe.
• Evaluation of industry activities advocating for titanium dioxide amid genotoxicity concerns.
• Examination of recent topics in European chemical strategy and the overall definition of nanomaterials.
• Identification of significant regulatory shifts regarding titanium dioxide and their implications for industry practices.
• Illustration of industry defense activities against genotoxicity claims.
• Discussion of the broader implications of the European chemical strategy on nanomaterials.